Redx Pharma Ltd. announced the Phase 2 ROCKETEER clinical trial design for its lead asset, RXC008, a GI-restricted, pan-ROCK inhibitor for the treatment of fibrostenotic Crohn's disease . More ...
Use of paclitaxel -coated balloon (PCB) dilation is a safe and effective adjunct option for restoring airway patency in patients with granulomatosis with polyangiitis (GPA), based on new data ...
Workup confirmed bilateral lens luxation and aortic root dilation, which the study authors identified as the cardinal ...
Viking Therapeutics rode strong obesity data before a major capital raise, while Longeveron’s mid-stage setback prompted ...
About fifty minutes into a film that premiered in Los Angeles earlier this month, the audience was told to close their eyes.
An artificial intelligence system trained on more than 150,000 retinal images predicted which children's vision would ...
KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), ...
Agomab Therapeutics NV announced positive outcomes from the 48-week Open-Label Extension study of the Phase 2a STENOVA trial ...
Corie Walsh, 40, was seen trying to harm herself with a knife after her 2-year-old son was found hanging in the basement ...
The FDA-aligned pivotal efficacy population includes 12 male patients receiving commercial-grade RP-A501 at the recalibrated dose. The first three patients treated under the modified protocol count ...
Background Heart failure (HF) remains associated with high mortality worldwide despite advances in guideline-directed therapy ...